HEL cell

SKU:BHC11101087
Bulk Pricing
Overview
Click light‑blue chips for details

HEL cell is a cell line derived from European (Male). It is commonly used as an in vitro model for 1 research. Growth characteristics: Adherent,suspension, Rounded. Supplied as cryopreserved cells with accompanying batch CoA and quality-control documentation.

Species Human
Disease model Erythroleukemia
Morphology Rounded
Growth Properties Adherent,suspension
Tissue Peripheral blood
Available Options

This cell line is available in the U.S. For non-profit users, please sign and submit the Non-Profit Supply Agreement to orders@biohippo.com before placing an order. For commercial users, please complete the CLEAR Form before ordering, as additional usage fees may apply based on the intended use. For further details, please contact orders@biohippo.com. Products ship after the required agreement is completed; typical delivery is 2–3 business days. Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 10^6 cells for adherent lines or 5 × 10^6 cells for suspension lines (refer to the batch CoA for details).

Options selector
Catalog no. Size
305022 1 cryovial
Field Specification
Species Human
HEL cells are a human erythroleukemia cell line that was established from the peripheral blood of a 30-year-old man with erythroleukemia in relapse after treatment for Hodgkin lymphoma in 1980. HEL cells are capable of spontaneous and induced globin synthesis, producing mainly G gamma and A gamma chains. These cells also express embryonic chains (epsilon, zeta) and alpha chains in minimal amounts, while beta chains are undetectable. HEL cells are round, large to occasionally giant polynucleated, single cells in suspension, with a few cells adherent. The expression of mutated JAK2 has been confirmed in these cells by RT-PCR and sequencing. HEL cells express several cell surface markers, including CD3-, CD13+, CD14-, CD19-, CD33+, CD41a+, CD71+, and CD235a+. According to research, hydroxyurea, a medicine routinely used to treat a variety of cancers, including erythroleukemia, may also regulate the death of HEL cells. HEL cell apoptosis produced by hydroxyurea may be connected to HEL cell terminal differentiation. Additionally, earlier research has shown that hydroxyurea may be crucial in controlling HEL cell proliferation and differentiation.

SKU:BHC11101087

  • cultureMedium: RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
  • supplements: Supplement the medium with 10% FBS
  • dissociationReagent: Accutase
  • doublingTime: 36 hours
  • subculturing: Gather the suspension cells in a 15 ml tube and gently wash the adherent cells with PBS lacking calcium and magnesium (use 3-5 ml for T25 flasks and 5-10 ml for T75 flasks). Apply Accutase (1-2 ml for T25 flasks, 2.5 ml for T75 flasks) ensuring full coverage of the cell layer. Allow the cells to incubate at room temperature for 10 minutes. Following incubation, combine and centrifuge both the suspension and adherent cells. After centrifugation, carefully resuspend the cell pellet and transfer the cell suspension into new flasks containing fresh medium.
  • fluidRenewal: 2 to 3 times per week
  • freezeMedium: As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Supplier Ads Slides show

Add dynamic ads with slider